Matrix Asset Advisors Has Lowered Its Stake in Merck & Co (MRK) by $2.22 Million; Open Text (OTEX) Holder Beutel Goodman & Co LTD Trimmed Its Stake

Open Text Corporation (NASDAQ:OTEX) Logo

Matrix Asset Advisors Inc decreased its stake in Merck & Co Inc (MRK) by 20.57% based on its latest 2018Q4 regulatory filing with the SEC. Matrix Asset Advisors Inc sold 29,197 shares as the company’s stock rose 5.36% with the market. The institutional investor held 112,752 shares of the health care company at the end of 2018Q4, valued at $8.62M, down from 141,949 at the end of the previous reported quarter. Matrix Asset Advisors Inc who had been investing in Merck & Co Inc for a number of months, seems to be less bullish one the $210.86B market cap company. The stock increased 0.79% or $0.64 during the last trading session, reaching $81.69. About 2.23 million shares traded. Merck & Co., Inc. (NYSE:MRK) has risen 51.53% since March 14, 2018 and is uptrending. It has outperformed by 47.16% the S&P500. Some Historical MRK News: 08/03/2018 – MERCK KGAA CEO: CONS HEALTH BUYER SHLD OFFER UNIT A GOOD FUTURE; 23/03/2018 – ANTICANCER AGENT LENVIMA® (LENVATINIB MESYLATE) APPROVED FOR ADDITIONAL INDICATION OF UNRESECTABLE HEPATOCELLULAR CARCINOMA (HCC) IN JAPAN, FIRST APPROVAL WORLDWIDE FOR LENVIMA FOR HCC; 23/04/2018 – EUROPEAN MEDICINES AGENCY VALIDATES TYPE Il VARIATION FOR MERCK’S KEYTRUDA® (PEMBROLIZUMAB) IN COMBINATION WITH PEMETREXED (ALIMTA®) AND PLATINUM CHEMOTHERAPY AS FIRST-LINE THERAPY IN METASTATIC; 25/05/2018 – IMFINZI® (Durvalumab) Significantly Improves Overall Survival in the Phase III Pacific Trial for Unresectable Stage III Non; 26/04/2018 – CAFC: GILEAD SCIENCES, INC. v. MERCK & CO., INC. [ERRATA] – Appeal #16-2302 – 2018-04-26; 23/05/2018 – Three Ebola patients escape Congo quarantine, medics race to control outbreak; 09/04/2018 – Merck: Keytruda Monotherapy Meets Primary Endpoint in Phase 3 Study; 07/05/2018 – Roche: FDA Grants Priority Review for Tecentriq in Lung Cancer Treatment; 26/03/2018 – BRISTOL-MYERS – CHMP ALSO RECOMMENDED APPROVAL OF TWO-WEEK OPDIVO DOSING OPTION OF 240 MG TO REPLACE WEIGHT-BASED DOSING FOR APPROVED MONOTHERAPIES IN EU; 19/04/2018 – MERCK KGAA MRCG.DE CFO SAYS BOOK GAIN FROM P&G PG.N TRANSACTION EXPECTED TO BE ABOUT 3 BLN EUR

Beutel Goodman & Co Ltd decreased its stake in Open Text Corp (OTEX) by 0.76% based on its latest 2018Q4 regulatory filing with the SEC. Beutel Goodman & Co Ltd sold 75,815 shares as the company’s stock rose 9.45% with the market. The institutional investor held 9.87 million shares of the edp services company at the end of 2018Q4, valued at $321.68 million, down from 9.94 million at the end of the previous reported quarter. Beutel Goodman & Co Ltd who had been investing in Open Text Corp for a number of months, seems to be less bullish one the $10.19 billion market cap company. The stock increased 0.03% or $0.01 during the last trading session, reaching $38.01. About 88,165 shares traded. Open Text Corporation (NASDAQ:OTEX) has risen 9.17% since March 14, 2018 and is uptrending. It has outperformed by 4.80% the S&P500. Some Historical OTEX News: 09/05/2018 – OPEN TEXT CORP OTEX.TO – ANNOUNCING A 15% INCREASE TO QUARTERLY CASH DIVIDEND TO $0.1518 PER SHARE; 09/05/2018 – Open Text 3Q Rev $685.9M; 10/05/2018 – OPEN TEXT CORP OTEX.TO : BARCLAYS RAISES TARGET PRICE TO C$59 FROM C$57; 09/05/2018 – OPENTEXT BOOSTS QTR DIV TO 15.18C/SHR FROM 13.2C, EST. 15.5C; 17/04/2018 – 13D CONF: ROBBINS SAYS OPEN TEXT MISPRICED, INEXPENSIVE COMPANY; 09/05/2018 – Open Text 3Q Net $58.8M; 17/04/2018 – Hedge fund manager Cliff Robbins reveals investment in software company Open Text; 09/05/2018 – Open Text 3Q Adj EPS 54c; 09/05/2018 – Open Text 3Q EPS 22c; 30/05/2018 – OPENTEXT REPORTS REPRICING & AMENDMENT OF CREDIT LINES

More notable recent Open Text Corporation (NASDAQ:OTEX) news were published by: Fool.ca which released: “DOCKS: Valuing Canada’s Tech Leaders – The Motley Fool Canada” on February 25, 2019, also Seekingalpha.com with their article: “Open Text Q2 2019 Earnings Preview – Seeking Alpha” published on January 30, 2019, Investorplace.com published: “7 Strong Buy Stocks the Street Loves – Investorplace.com” on March 01, 2019. More interesting news about Open Text Corporation (NASDAQ:OTEX) were released by: Fool.ca and their article: “With 20% Upside, Is This Still the Best Valued Tech Stock on the TSX? – The Motley Fool Canada” published on February 12, 2019 as well as Seekingalpha.com‘s news article titled: “Open Text Corporation 2019 Q2 – Results – Earnings Call Slides – Seeking Alpha” with publication date: January 31, 2019.

Analysts await Open Text Corporation (NASDAQ:OTEX) to report earnings on May, 8. They expect $0.08 EPS, down 63.64% or $0.14 from last year’s $0.22 per share. OTEX’s profit will be $21.44 million for 118.78 P/E if the $0.08 EPS becomes a reality. After $0.39 actual EPS reported by Open Text Corporation for the previous quarter, Wall Street now forecasts -79.49% negative EPS growth.

Beutel Goodman & Co Ltd, which manages about $36.47B and $11.75B US Long portfolio, upped its stake in Comcast Corp (NASDAQ:CMCSA) by 48,997 shares to 4.26M shares, valued at $106.39M in 2018Q4, according to the filing. It also increased its holding in Amgen Inc (NASDAQ:AMGN) by 56,365 shares in the quarter, for a total of 665,548 shares, and has risen its stake in Magna Intl Inc (NYSE:MGA).

Matrix Asset Advisors Inc, which manages about $977.80 million and $538.59M US Long portfolio, upped its stake in Occidental Pete Corp Del (NYSE:OXY) by 9,202 shares to 242,644 shares, valued at $14.89 million in 2018Q4, according to the filing. It also increased its holding in Metlife Inc (NYSE:MET) by 7,583 shares in the quarter, for a total of 432,849 shares, and has risen its stake in United Parcel Service Inc (NYSE:UPS).

Analysts await Merck & Co., Inc. (NYSE:MRK) to report earnings on May, 7. They expect $1.08 EPS, up 2.86% or $0.03 from last year’s $1.05 per share. MRK’s profit will be $2.79B for 18.91 P/E if the $1.08 EPS becomes a reality. After $1.04 actual EPS reported by Merck & Co., Inc. for the previous quarter, Wall Street now forecasts 3.85% EPS growth.

Merck & Co., Inc. (NYSE:MRK) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.